Rapamycin-induced remission of Kaposi's sarcoma is not associated with expansion of cytotoxic T-lymphocyte subsets

We present a case of post-transplantation Kaposi's sarcoma (KS) successfully treated by conversion to rapamycin. Clinical and histological resolution was observed within 6 months of commencing rapamycin. Also, vascular endothelial growth factor (VEGF) staining in the biopsy samples resolved fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Stephen B., Summers, Shaun A., Amlot, Peter L., Sheaff, Michael T., Neild, Guy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421263/
https://www.ncbi.nlm.nih.gov/pubmed/25983921
http://dx.doi.org/10.1093/ndtplus/sfn068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421263/
https://www.ncbi.nlm.nih.gov/pubmed/25983921
http://dx.doi.org/10.1093/ndtplus/sfn068

Ejemplares similares